Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission

2019

a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

British Journal of Haematology , Volume 184 - Issue 4 p. 643- 646

Additional Metadata
Persistent URL	doi.org/10.1111/bjh.15131, hdl.handle.net/1765/115215
Journal	British Journal of Haematology
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ofran, Y., Beohou, E., Labopin, M., Blaise, D., Cornelissen, J., de Groot, M., … Nagler, A. (2019). Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission. British Journal of Haematology, 184(4), 643–646. doi:10.1111/bjh.15131

Publication